BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lin J, Yang W, Jiang N, Zheng Q, Huang J, Huang N, Li A, Jiang H. Incidence and prediction of seed migration to the chest after iodine-125 brachytherapy for hepatocellular carcinoma. Brachytherapy 2017;16:1252-6. [DOI: 10.1016/j.brachy.2017.07.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
Number Citing Articles
1 Lin J, Jiang H, Yang W, Jiang N, Zheng Q, Huang N, Wang X, Li A, Huang J. Predictive factors of benefit from iodine-125 brachytherapy for hepatocellular carcinoma with portal vein tumor thrombosis. Brachytherapy. 2018;pii:S1538-4721(18)30424-0. [PMID: 30467014 DOI: 10.1016/j.brachy.2018.10.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
2 Zhao J, Zhi Z, Zhang H, Zhao J, Di Y, Xu K, Ma C, Liu Z, Sui A, Wang J. Efficacy and safety of CT-guided 125I brachytherapy in elderly patients with non-small cell lung cancer. Oncol Lett 2020;20:183-92. [PMID: 32565946 DOI: 10.3892/ol.2020.11550] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Lin J, Yan L, Wang X, Wu Z, Ke K, Lin X, Huang N, Yang W, Xia C. Administration of Iodine-125 Seeds Promotes Apoptosis in Cholangiocarcinoma through the PI3K/Akt Pathway. Advances in Polymer Technology 2022;2022:1-6. [DOI: 10.1155/2022/6934934] [Reference Citation Analysis]